We are live on ! Find out more
WFM

Wilmington Funds Management Portfolio holdings

AUM $988M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+26.05%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$988M
AUM Growth
+$67.7M
Cap. Flow
+$35.7M
Cap. Flow %
3.61%
Top 10 Hldgs %
10.81%
Holding
873
New
103
Increased
253
Reduced
220
Closed
127

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.38M
2
AGN
Allergan Inc
AGN
+$5.74M
3
OII icon
Oceaneering
OII
+$4.45M
4
FRX
FOREST LABORATORIES INC
FRX
+$3.94M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$3.61M

Top Sells

Rank Stock Value
1
CTXS
Citrix Systems Inc
CTXS
+$5.03M
2
XOM icon
ExxonMobil
XOM
+$4.42M
3
GE icon
GE Aerospace
GE
+$3.28M
4
CVX icon
Chevron
CVX
+$2.84M
5
HLF icon
Herbalife
HLF
+$2.82M

Sector Composition

Rank Sector Weight
1 Industrials 15.33%
2 Consumer Discretionary 12.29%
3 Healthcare 11.76%
4 Technology 11.66%
5 Real Estate 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMB icon
201
Kimberly-Clark
KMB
$37.5B
$1.04M 0.11%
9,742
+1,148
+13% +$122K
VER
202
DELISTED
VEREIT, Inc.
VER
$1.03M 0.1%
16,492
+12,944
+365% +$832K
PXD
203
DELISTED
Pioneer Natural Resource Co.
PXD
$1.02M 0.1%
4,420
+1,300
+42% +$268K
ALXN
204
DELISTED
Alexion Pharmaceuticals
ALXN
$1.01M 0.1%
6,440
+2,400
+59% +$379K
MDT icon
205
Medtronic
MDT
$111B
$1M 0.1%
15,718
-3,542
-18% -$215K
EXPO icon
206
Exponent
EXPO
$3.15B
$978K 0.1%
52,804
– –
KR icon
207
Kroger
KR
$36.3B
$976K 0.1%
39,472
+14,800
+60% +$345K
EXP icon
208
Eagle Materials
EXP
$6.86B
$972K 0.1%
10,315
+800
+8% +$69.9K
MU icon
209
Micron Technology
MU
$927B
$968K 0.1%
29,370
+5,800
+25% +$158K
INVX
210
Innovex International
INVX
$1.79B
$968K 0.1%
8,859
+1,100
+14% +$118K
DRE
211
DELISTED
Duke Realty Corp.
DRE
$968K 0.1%
53,310
– –
CAT icon
212
Caterpillar
CAT
$387B
$967K 0.1%
8,900
-3,200
-26% -$336K
POT
213
DELISTED
Potash Corp Of Saskatchewan
POT
$952K 0.1%
25,075
-12,799
-34% -$462K
BC icon
214
Brunswick
BC
$5.33B
$943K 0.1%
22,374
-1,800
-7% -$76K
CORE
215
DELISTED
Core Mark Holding Co., Inc.
CORE
$936K 0.09%
41,032
– –
FCFS icon
216
FirstCash
FCFS
$8.97B
$933K 0.09%
16,207
– –
ALLY icon
217
Ally Financial
ALLY
$13.4B
$925K 0.09%
+38,700
New +$940K
AXE
218
DELISTED
Anixter International Inc
AXE
$916K 0.09%
9,150
-270
-3% -$26.6K
CCI icon
219
Crown Castle
CCI
$33.1B
$902K 0.09%
+12,140
New +$910K
CRVL icon
220
CorVel
CRVL
$3.14B
$896K 0.09%
59,526
-3,000
-5% -$46.8K
CTSH icon
221
Cognizant
CTSH
$23.8B
$886K 0.09%
18,120
+6,200
+52% +$302K
SHOO icon
222
Steven Madden
SHOO
$3.22B
$885K 0.09%
38,708
– –
NFLX icon
223
Netflix
NFLX
$301B
$881K 0.09%
140,000
+70,000
+100% +$379K
LO
224
DELISTED
LORILLARD INC COM STK
LO
$879K 0.09%
14,420
+4,600
+47% +$267K
LPT
225
DELISTED
Liberty Property Trust
LPT
$878K 0.09%
23,140
-3,300
-12% -$125K
7 8
9
10 11

Similar funds

SCM
Stux Capital Management New York $766M AUM 28.03% 1-Year Est. Return
MIU
Man Investments (UK) London, United Kingdom $1.29B AUM 31.85% 1-Year Est. Return
SR
Swiss Reinsurance Zurich, Switzerland $664M AUM 11.24% 1-Year Est. Return
CH
Cavalane Holdings Sydney, Australia $558M AUM
WTIM
Wilmington Trust Investment Management Wilmington, Delaware $492M AUM 25.19% 1-Year Est. Return
FOAM
Five Oceans Asset Management Sydney, Australia $438M AUM 24.83% 1-Year Est. Return
BII
Baring International Investment London, United Kingdom $1.57B AUM 24.97% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Wilmington Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Wilmington Funds Management held 873 positions worth $988M, up 7.4% from $920M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Wilmington Funds Management deployed $35.7M of net new capital in Q2 2014, opening 103 new positions and adding to 253 existing holdings. Its largest new stake was AstraZeneca: 88,300 shares worth $6.56M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Citrix Systems Inc, an estimated $5.03M trimmed.

  • Wilmington Funds Management's largest Q2 2014 buy was AstraZeneca: 88,300 shares worth $6.56M.
  • Wilmington Funds Management added most to Allergan Inc in Q2 2014, an estimated $5.74M increase.
  • Wilmington Funds Management's biggest Q2 2014 reduction was Citrix Systems Inc, cutting an estimated $5.03M.
  • Wilmington Funds Management fully exited Wolfspeed in Q2 2014, selling an estimated $1.9M.
  • Wilmington Funds Management's ten largest holdings make up 11% of its $988M portfolio in Q2 2014.
  • Wilmington Funds Management opened 103 new positions and closed 127 in Q2 2014.
  • Wilmington Funds Management's portfolio value rose 7.4% quarter-over-quarter to $988M.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.